B-cell subsets of rheumatology patients on Rituximab therapy(Version1)

• Research type

  Research Study

• Full title

  Assess the impact of anti-CD20 monoclonal antibody (Rituximab) treatment on B-cell subsets of rheumatology patients using the EUROclass classification

• IRAS ID

  132355

• Contact name

  MALINI BHOLE

• Contact email

  malini.bhole@nhs.net

• Sponsor organisation

  Dudley Group Of Hospitals NHS Trust

• REC name

  London - Central Research Ethics Committee

• REC reference

  13/LO/1547

• Date of REC Opinion

  1 Oct 2013

• REC opinion

  Favourable Opinion